1 / 80

METABOLIC DISEASE OF SPINE-OSTEOPOROSIS

METABOLIC DISEASE OF SPINE-OSTEOPOROSIS. Presenter: DR.LEMAYIAN PETER Supervisor: DR. OMBACHI. Skeletal d’se characterised by:. Low bone mass Micro-achitectural breakdown of bone tissue. “silent killer” Preventable d’se Devastating physical, psychosocial and economical consequence

tuyet
Télécharger la présentation

METABOLIC DISEASE OF SPINE-OSTEOPOROSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. METABOLIC DISEASE OF SPINE-OSTEOPOROSIS Presenter: DR.LEMAYIAN PETER Supervisor: DR. OMBACHI

  2. Skeletal d’se characterised by: • Low bone mass • Micro-achitectural breakdown of bone tissue

  3. “silent killer” • Preventable d’se • Devastating physical, psychosocial and economical consequence • Increasingly becoming a global problem-most common metabolic bone d’se afflicting approx. 200m worldwide.

  4. WHO DEFINITION:

  5. This definition applies to postmenopausal women and men >50yrs • T-Score= patient’s BMD BMD of control subjects who are at their peak BMD • Z-Score=patient’s BMD BMD of patients matched for age and sex Z-Scores used in premenopausal women, children and men<50yrs

  6. PATHOPHYSIOLOGY • HALLMARK: reduced skeletal mass due to imbalance btn bone resorption and formation • Failure to build bone reserve from childhood • Bone loss • Aging with loss of gonadal function • Bone loss accelerates rapidly in women during the first years after menopause

  7. a) Estrogen deficiency leads to… • ↑ expression of RANKL by osteoblasts • ↓ release of OPG • ↑recruitment of pre-osteoclasts→↑differentiation and prolonged survival of osteoclasts via IL-1,IL-6,TNFᾳ. • T-Cells inhibit osteoblastic differentiation and activity with premature apoptosis of osteoblasts through cytokines e.g. IL-7

  8. Increased sensitization of bone to the effects of PTH • ↑osteoclastic apoptotic activity via ↑production of TGFᵝ

  9. b) Aging • Progressive ↓ in supply of osteoblasts • Reduced Ca2+ uptake from GIT • Bone resorption exceeds bone formation from 3rd decade • Women lose-30-40% of cortical bone -50% of trabecular bone • Men lose-15-20% of cortical bone -25-30% of trabecular bone

  10. c) Ca²⁺deficiency • →2° hyperPTH -↓ renal excretion of Ca2+ -↑ renal production of 1,25-(OH)2-D (calcitriol)→↑ca2+ absorption from the gut →↑bone resorption

  11. d) Vit D Deficiency • Impaired absorption of Ca2+ from gut • Compensatory mechanism:-Leads to hyperPTH→↑production of calcitriol from the kidneys • PTH and vit.D have their effect on bone being mediated via binding to osteoblasts and stimulating RANK/RANKL pathway • Osteoclasts do not have receptors for Vit.D or PTH

  12. Osteoporotic Fractures • Aka Insufficiency/ fragility fractures • Mostly from low-energy trauma/minor loads • Vertebral bodies-1rly cancellous with interconnected horizontal and vertical trabeculae. • In osteoporosis there’s ↓ in both bone mass and this internal interconnectivity(BUT preferentially disruption is in the horizontal trabeculae)→? Reason→?overaggresive osteoclastic resorption

  13. Rosen and Tenenhouse cadaveric study: • As many as 200-450 horizontal trabeculae fractures per vertebral body in various stages of healing→cumulatively leads to weakening of cancellous bony structure

  14. Osteoporosis Vs Osteomalacia • Normal human skeleton→60% mineral 40% organic material (collagen) • Osteoporosis-mineral: collagen ratio within normal tho’ both are significantly ↓; bone is porous and brittle • Osteomalacia-mineral is reduced relative to organic content; bone is soft.

  15. Classification of osteoporosis: • Localised 1° • Generalised 2°

  16. 1° Osteoporosis (A) JUVENILE • Children/young adults; both sexes • 8-14 yrs • Normal gonadal function • Hallmark: abrupt bone pain/ fracture following minor trauma

  17. (B) IDIOPATHIC • PMO(TYPE 1)-high-turnover osteoporosis • Women>50-65yrs • Phase of accelerated bone loss primarily trabecular bone • Predorminantly increased osteoclastic activity • Fracture vertebrae and distal forearm common • Vertebral # occur more often in the 7th decade of life.

  18. b) age-related/senile osteoporosis(TYPE 2) -Low-turnover osteoporosis -gradual slow down in osteoblastic activity. • Men and women >70 yrs • Fractures in cortical and trabecular bone • Wrist, vertebrae and hip fractures common

  19. 2° Osteoporosis

  20. STAGES • STAGE 1: loss of horizontal trabeculations • STAGE 2: loss of vertical trabeculae • STAGE 3: loss of both horizontal and vertical trabeculae with resultant cavitation of the vertebral body

  21. RISK FACTORS National Osteoporosis Foundation (NOF) classifies them into: • Modifiable: • physical inactivity • drugs, alcohol, cigarette smoking • deficiency states • Thin build/small stature(body wght <127lbs/ BMI<20-25 kg/m² in men), • >10% body weight loss in men • Androgen deprivation therapy in men • Previous fragility fracture

  22. b) Non-modifiable: • age (>50yrs) • sex(F:M=4:1) • race(caucasian/asian) • genetics(+ve family history) • amenorrhoea, late menarche, early menopause • post-hysterectomy and oophorectomy, • androgen/ estrogen def.

  23. Pneumonic=OSTEOPOROSIS • O=lOw ca2+ • S=Seizure drugs • T=Thin build • E=Ethanol intake • O=hypOgonadism • P=Previous fracture • 0=thyrOid excess • R=Race • O=Other realtives with osteoporosis • S=Steroids • I=Inactivity • S=Smoking

  24. EPIDEMIOLOGY • 10m Americans affected(80% women)-NOF • 34M have ↓ bone mass with ↑ risk for osteoporosis • 1.5m-2m osteoporotic fractures/yr (700,000 spinal #; 300,000 hip #; 200,000 wrist #) • 1 in every 2 women and 1 in every 5 men will eventually experience osteoporotic # • Men have a higher prevalence of 2° osteoporosis

  25. RACIAL DEMOGRAPHICS

  26. Osteoporosis-related fractures result in annual direct expenditure of $12.2b-17.9b • Leading cause of fractures in the elderly • Women>50yrs have about 50% lifetime fracture rate due to osteoporosis and about 80% of all fractures in pple aged >50yrs.

  27. prognosis • Good if bone loss is detected early • Incase of #→ may lead to chronic pain, disability, prolonged immobilisation, death

  28. Vertebral compression fractures • 2/3 are asymptomatic and occur slowly • Associated with ↑morbidity and mortality • Mortality also correlates with number of vertebral # • Often occurs with minimal stress • Mostly affected-middle/lower thoracic and upper lumbar

  29. As posture worsens and kyphosis progresses→difficulty with balance, back pains, resp. compromise,↑ risk of pneumonia • ↓ QOL • Presence of a # at one vertebral level→5-fold ↑ risk of getting another

  30. CLINICAL PRESENTATIONS • Episode of acute back pain after bending, coughing,lifting, a fall, minor trauma • Pain-sharp, nugging, dull; exacerbated by movt; may radiate to the abdomen • Progressive kyphosis with loss of height • +/- localised pain • Paravertebral muscle spasm exacerbated by activity/ reduced by lying supine.

  31. Complications: • Chronic pain • ↑morbidity and mortality • ↓ QOL • Prolonged immobility • Severe kyphosis • Spinal deformities→”dowager’s hump”→loss of 1-2’ of height by 7th decade of life • Loss of self-esteem→depression

  32. PHYSICAL EXAM • Inspection • Palpation • Height measurement • Active/passive ROM • Neurological exam

  33. Signs esp in the elderly that may indicate ↑risk of a fall-gait problems, orthostatic hypotn, LL weakness, cognitive impairment • Findings of subtle collagen defects:-short 5th digit, dentinogenesis imperfecta, hyperlaxity, hearing loss, pes planus, bunions, blue sclera

  34. DDX • Osteomalacia • Tumors(osteolytic) • Infections • Osteonecrosis • Other bone-softening metabolic disorders • Mets • Leukaemia/lymphoma • Osteogenesisimperfecta • Renal osteodystrophy • Multiple myeloma • Scurvy • Paget’s disease • Sickle cell anaemia • Homocystinuria/homocystinaemia

  35. WHO-Fracture-Risk algorithm(FRAX) • Developed to calculate 10yr probability of any major osteoporotic # in a given patient • Take into a/c BMD and other clinical risk fxtrs • NOF recommends RX for patients with WHO-10yr-probability of major osteoporosis-related # of >20% (or >30% for hip #) • This algorithm is useful in identifying patients most likely to benefit from Rx.

  36. SCREENING • Women >50yrs of age • For men, not carried out routinely US preventive Services Task Force(USPSTF)/ American College of Physicians(ACP) recommendations: Indications for screening in men • Those with 10yr risk for osteoporotic # equal to or greater than that for 65yr old women who have no additional risk factors

  37. INVESTIGATIONS • LAB WORKUP • To establish baseline conditions: -CBC -Serum Ca²⁺,mg²⁺,po4-,Fe2+/ferritin levels -LFTs -TFTs -Vit. D levels -Cr/BUN

  38. b) To exclude 2° causes • 24 hr-urinary Ca2+ levels • PTH level • Testosterone/gonadotropin level • ESR/ CRP • Urinary free cortisol levels/ dexamethasone suppression test • BMA • Serum/Urinary protein electrophoresis

  39. ii) Biochemical markers of bone turnover • Reflect bone formation and resorption • Maybe ↑in high-bone turnover states and may also be useful in some patients for monitoring early response to treatment

  40. SERUM MARKERS OF BONE FORMATION • Bone specific alkaline phosphatase(BSAP) • Osteocalcin(OC)-if high, indicates a high turnover osteoporosis • Carboxyterminal propeptide of type 1 collagen(PICP) • Aminoterminal propeptide of type 1 collagen(PINP)

  41. SERUM MARKERS OF BONE RESORPTION • Cross-linked C-Telopeptide of type 1 collagen(ICTP) • Tartrate-resisitant acid phosphatase • N-Telopeptide of collagen cross-links(NTx) • C-telopeptide of collagen cross-links(CTx)

  42. URINARY MARKERS OF BONE RESORPTION • Hydroxyproline • Free and total pyridinolines(Pyd) • Free and total deoxypyridinolines(Dpd) • NTx • CTx

  43. iii) IMAGING • Plain radiography -to assess overall skeletal intergrity -suspected # -if patient has lost>1½” of height • Can suggest presence of osteopaenia or bone loss though cannot diagnose osteoporosis

  44. Osteoporosis predorminantly affects trabecular bone rather than cortical bone • Cortical bone not affected by osteoporosis until >30% of bone loss has occurred • 30-80% of bone mineral must be lost before radiographic lucency becomes apparent.

  45. (b) Densitometry • Dual-Energy X-Ray Absorptiometry(DXA) -quantifies bone loss -standard for evaluation of BMD -not as sensitive as QCT for detecting early trabecular bone loss, but it provides rapid scanning times, is less costly and precise -used to calculate BMD at the lumbar spine, hip,prox. Femur and wrist -data is reported as T and Z-scores

  46. 2) Single-photon Absorptiometry(SPA) -precise and with low- radiation exposure -relatively insensitive for detecting early-stage osteoporosis coz it measures cortical rather than trabecular bone.

  47. 3) Dual-Photon Absorptiometry(DPA) -Can measure BMD in the spine and prox. Femur -limited by poor reproducibility, prolonged scanning times and artifacts caused by vascular calcifications.

  48. 4) Computed Tomography • Quantitative CT Scanning(QCT) -assesses BMD only at the spine -can be used in both adults and children -is the most sensitive method for diagnosing osteoporosis coz it measures trabecular bone within the vertebral body. -cf with DXA, is more expensive, poor reproducibility, possible interference by osteophytes, higher radiation dose

More Related